Evolent Health Inc (EVH)
27.76
-0.06
(-0.20%)
USD |
NYSE |
Apr 30, 16:00
27.76
0.00 (0.00%)
After-Hours: 16:55
Evolent Health Debt to Equity Ratio: 0.5592 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.5592 |
| September 30, 2023 | 0.5483 |
| June 30, 2023 | 0.579 |
| March 31, 2023 | 0.4892 |
| December 31, 2022 | 0.4805 |
| September 30, 2022 | 0.4817 |
| June 30, 2022 | 0.4618 |
| March 31, 2022 | 0.4624 |
| December 31, 2021 | 0.3109 |
| September 30, 2021 | 0.3914 |
| June 30, 2021 | 0.3797 |
| March 31, 2021 | 0.3705 |
| December 31, 2020 | 0.4679 |
| September 30, 2020 | 0.4528 |
| June 30, 2020 | 0.4634 |
| March 31, 2020 | 0.3502 |
| December 31, 2019 | 0.3184 |
| September 30, 2019 | 0.2057 |
| June 30, 2019 | 0.1996 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.203 |
| December 31, 2018 | 0.1932 |
| September 30, 2018 | 0.1175 |
| June 30, 2018 | 0.117 |
| March 31, 2018 | 0.1166 |
| December 31, 2017 | 0.1201 |
| September 30, 2017 | 0.1188 |
| June 30, 2017 | 0.1407 |
| March 31, 2017 | 0.1608 |
| December 31, 2016 | 0.1712 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1996
Minimum
Jun 2019
0.579
Maximum
Jun 2023
0.4196
Average
0.4618
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| American Shared Hospital Services | 0.7773 |
| Novo Integrated Sciences Inc | 0.1478 |
| Astrana Health Inc | 0.4533 |
| Cryo-Cell International Inc | -1.019 |
| P3 Health Partners Inc | 0.7621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.680B |
| Total Liabilities (Quarterly) | 1.613B |
| Shareholders Equity (Quarterly) | 1.068B |
| Current Ratio | 1.014 |
| Net Debt Paydown Yield | -0.98% |